ARCH Venture Fund IX, L.P.'s Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Feb 12, 2024
- Accession no.
- 0001062993-24-002840
- Filed
- Feb 12, 2024, 5:43 PM ET
- Trade date
- Feb 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| ARCH Venture Fund IX, L.P.CIK 0001666306 | 10% Owner |
| ARCH Venture Fund IX Overage, L.P.CIK 0001666307 | 10% Owner |
| ARCH Venture Partners IX Overage, L.P.CIK 0001723172 | 10% Owner |
| ARCH Venture Partners IX, L.P.CIK 0001723173 | 10% Owner |
| ARCH Venture Partners IX, LLCCIK 0001723174 | 10% Owner |
| ARCH Venture Fund X, L.P.CIK 0001757011 | 10% Owner |
| ARCH Venture Fund X Overage, L.P.CIK 0001757017 | 10% Owner |
| ARCH Venture Partners X Overage, L.P.CIK 0001768905 | 10% Owner |
| ARCH Venture Partners X, LLCCIK 0001769012 | 10% Owner |
| ARCH Venture Partners X, L.P.CIK 0001782583 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +363,637 | $5.50 | +$2,000,003.5 | 10,667,387 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.